{"abstract":"The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, on behalf of the Centers for Disease Control and Prevention, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to University Health Network, located in Toronto, Canada, its rights to the technologies and the patent applications listed in the SUPPLEMENTARY INFORMATION section of this notice.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2024/04/19/2024-08361.html","cfr_references":[],"citation":"89 FR 28791","comment_url":null,"comments_close_on":"2024-05-06","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases on or before May 6, 2024 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2024-08361","effective_on":null,"end_page":28791,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2024/04/19/2024-08361.xml","html_url":"https://www.federalregister.gov/documents/2024/04/19/2024-08361/prospective-grant-of-exclusive-license-inter-institutional-agreement-institution-lead-polyvalent","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2024-08361?publication_date=2024-04-19","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2024-04-19/2024-08361/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":98,"last_updated":"2026-10-22 16:15:06 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-04-19/pdf/2024-08361.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-08361.pdf?1713444344","publication_date":"2024-04-19","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2024/04/19/2024-08361.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2024-04-19T09:51:48Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":28791,"subtype":null,"title":"Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Polyvalent Vaccines and Methods for Making Them","toc_doc":"Inter-Institutional Agreement-Institution Lead: Polyvalent Vaccines and Methods for Making Them","toc_subject":"Licenses; Exemptions, Applications, Amendments, etc.:\n","topics":[],"type":"Notice","volume":89}